MedTrace Logo

Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole

NCT02236728 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 497

Last updated 2014-09-11

No results posted yet for this study

Summary

The primary objective of this study was to describe neurologists' population of patients treated with pramipexole and suffering from Parkinson's disease (so called 'primary care' population).

The secondary objectives were:

* Evaluate the mean dose of pramipexole prescribed under actual conditions of use depending on the severity of the disease.
* Evaluate the reasons for choosing pramipexole as treatment.
* Identify the patient profiles determining the choice of dose of pramipexole prescribed

Conditions

  • Parkinson Disease

Interventions

DRUG

Pramipexole

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2008-11-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02236728 on ClinicalTrials.gov